Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples

Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence...

Full description

Saved in:
Bibliographic Details
Published inVirology journal Vol. 15; no. 1; p. 145
Main Authors Martelli, Francesco, Macera, Lisa, Spezia, Pietro Giorgio, Medici, Chiara, Pistello, Mauro, Guasti, Daniele, Romagnoli, Paolo, Maggi, Fabrizio, Giannecchini, Simone
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 20.09.2018
BioMed Central
BMC
Subjects
Anelloviridae
Anelloviruses
Annexin II
CD63 antigen
CD81 antigen
Centrifugation
Deoxyribonuclease
deoxyribonucleases
Detergents
DNA
DNA viral load
Electron microscopy
Exosomes
freeze-thaw cycles
Freezing
Genetic aspects
hepatitis C
HIV
HIV infections
HIV, transplant recipients
Human immunodeficiency virus
kidney transplant
Kidney transplantation
Nanoparticles
Patients
Physiological aspects
polymerase chain reaction
Quantitation
Thawing
Torquetenovirus
vertebrate viruses
Vesicles
Viral genetics
viral load
Viral persistence
Viremia
Western blotting
Italy
DNA viral load
Exosomes
Torquetenovirus
Viral persistence
Anelloviruses
HIV, transplant recipients
Online AccessGet full text

Cover

Abstract Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 10 /ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 10 copies/ml showed to contain 6.3 × 10 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 10 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 10 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
AbstractList Background Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. Methods TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. Results Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 x 10.sup.9/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 x 10.sup.4 copies/ml showed to contain 6.3 x 10.sup.2 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 10.sup.2 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 x 10.sup.3 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. Conclusions Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host. Keywords: Anelloviruses, Torquetenovirus, Exosomes, DNA viral load, Viral persistence, HIV, transplant recipients
BACKGROUND: Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. METHODS: TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. RESULTS: Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 10⁹/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 10⁴ copies/ml showed to contain 6.3 × 10² TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 10² TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 10³ copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. CONCLUSIONS: Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 10 /ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 10 copies/ml showed to contain 6.3 × 10 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 10 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 10 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
Background Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. Methods TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. Results Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 109/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 104 copies/ml showed to contain 6.3 × 102 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 102 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 103 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. Conclusions Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
Abstract Background Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. Methods TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. Results Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 109/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 104 copies/ml showed to contain 6.3 × 102 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 102 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 103 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. Conclusions Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated. TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay. Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 x 10.sup.9/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 x 10.sup.4 copies/ml showed to contain 6.3 x 10.sup.2 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 10.sup.2 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 x 10.sup.3 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed. Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated.BACKGROUNDTorquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful interaction with the host. Increasing evidence have shown some human viruses exploit extracellular vesicles thereby helping viral persistence in the host. Here, the presence of TTV in extracellular vesicles circulating in human plasma was investigated.TTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay.METHODSTTV DNA was quantified in plasma-derived exosomes from 122 samples collected from 97 diseased patients and 25 healthy donors. Exosomes enriched vesicles (EEVs) were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81 and annexin II protein and, finally, by electron microscopy (EM). Presence and quantitation of TTV DNA were assessed with an universal single step real-time TaqMan PCR assay.Preliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 109/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 104 copies/ml showed to contain 6.3 × 102 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 102 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 103 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed.RESULTSPreliminary investigation showed that the human plasma extracted extracellular vesicles exhibited a main size of 70 nm, had concentration of 2.5 × 109/ml, and scored positive for tetraspanin CD63, CD81 and annexin II, typical characteristic of the exosomes vesicles. EEVs extracted from pooled plasma with TTV DNA viremia of 9.7 × 104 copies/ml showed to contain 6.3 × 102 TTV copies/ml, corresponding to 0.65% of total viral load. Important, TTV yield changed significantly following freezing/thawing, detergents and DNAse treatment of plasma before EEVs extraction. EEVs purified by sucrose-density gradient centrifugation and analysis of gradient fraction positive for exosomes marker CD63 harbored 102 TTV copies/ml. Moreover, EM evidenced the presence of TTV-like particles in EEVs. Successive investigation of plasma EEVs from 122 subjects (37 HIV-positive, 20 HCV infected, 20 HBV infected, 20 kidney transplant recipients, and 25 healthy) reported TTV DNA detection in 42 (34%) of the viremic samples (37 were from diseased patients and 5 from healthy people) at a mean level of 4.8 × 103 copies/ml. The examination of EEVs selected samples reported the presence of TTV genogroup 1, 3, 4 and 5, with genogroup 3 highly observed.Collectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.CONCLUSIONSCollectively, although these observations should be confirmed by further studies, circulation of TTV particles in EEVs opens new avenues and mechanistic insights on the molecular strategies adopted by anelloviruses to persist in the host.
ArticleNumber 145
Audience Academic
Author Martelli, Francesco
Spezia, Pietro Giorgio
Pistello, Mauro
Medici, Chiara
Romagnoli, Paolo
Guasti, Daniele
Giannecchini, Simone
Maggi, Fabrizio
Macera, Lisa
Author_xml – sequence: 1
  givenname: Francesco
  surname: Martelli
  fullname: Martelli, Francesco
– sequence: 2
  givenname: Lisa
  surname: Macera
  fullname: Macera, Lisa
– sequence: 3
  givenname: Pietro Giorgio
  surname: Spezia
  fullname: Spezia, Pietro Giorgio
– sequence: 4
  givenname: Chiara
  surname: Medici
  fullname: Medici, Chiara
– sequence: 5
  givenname: Mauro
  surname: Pistello
  fullname: Pistello, Mauro
– sequence: 6
  givenname: Daniele
  surname: Guasti
  fullname: Guasti, Daniele
– sequence: 7
  givenname: Paolo
  surname: Romagnoli
  fullname: Romagnoli, Paolo
– sequence: 8
  givenname: Fabrizio
  surname: Maggi
  fullname: Maggi, Fabrizio
– sequence: 9
  givenname: Simone
  orcidid: 0000-0003-3374-7621
  surname: Giannecchini
  fullname: Giannecchini, Simone
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30236130$$D View this record in MEDLINE/PubMed
BookMark eNqFkl2L1DAUhousuB_6A7yRgjd60TWfTXsjLIsfAwuCriB4EdIk7WRokzFph51_76mzq9tFMblIOHnel9PT9zQ78sHbLHuO0TnGVfkmYVJXvEC4KjDivNg_yk6wYLRghHw7unc_zk5T2iBESSnqJ9kxRYSWmKKT7Pt1iD8mO1ofdi5OKTdw16MLPnc-tzchhcGm3Pro9NqafGeT0z1UtIt66tXofDeT62lQPt_2Kg0qT2rYAvM0e9yqPtlnt-dZ9vX9u-vLj8XVpw-ry4urQpdEjIXB1DCjTaUIEbAaLSxHghAjmlZjXQlsGa2oEbXFBImWo4rVpdKtJaQsK3qWrQ6-JqiN3EY3qLiXQTn5qxBiJ1Uc57YlpgTXtUaUIsFUo2qGMNe2bTRsSmevtwev7dQM1mjrx6j6henyxbu17MJOlpjViDIweHVrEAMMNo1ycEnbvlfehilJgkVJa1FBC_9HYXFSYQ7oywfoJkzRw1SBIqRm8P_LP1Sn4FudbwO0qGdTecG5EJhRToA6_wsF29jBaUhY66C-ELxeCIAZ7c3YqSklufryecm-uD-_34O7SxwA4gDoGFKKtpXajWoOHHTheomRnLMtD9mWkG05Z1vuQYkfKO_M_635CQ1Z-h0
CitedBy_id crossref_primary_10_3390_vaccines11101532
crossref_primary_10_1016_j_virusres_2019_03_023
crossref_primary_10_3389_fviro_2021_782886
crossref_primary_10_1016_j_amolm_2023_100006
crossref_primary_10_1097_TP_0000000000004153
crossref_primary_10_4103_NRR_NRR_D_24_00243
crossref_primary_10_1186_s12866_024_03187_7
crossref_primary_10_4103_abr_abr_169_19
crossref_primary_10_5500_wjt_v10_i11_291
crossref_primary_10_1016_j_prp_2024_155451
crossref_primary_10_1080_23744235_2022_2149852
crossref_primary_10_1002_biot_201900225
crossref_primary_10_1016_j_cmi_2020_01_011
crossref_primary_10_1093_femsre_fuaa007
crossref_primary_10_3390_v17030334
crossref_primary_10_3390_microorganisms9071357
crossref_primary_10_1016_j_jcv_2020_104687
crossref_primary_10_1016_j_ttbdis_2019_03_005
crossref_primary_10_1177_1352458519879303
crossref_primary_10_3389_fviro_2022_821298
crossref_primary_10_1016_j_trre_2019_03_004
crossref_primary_10_18097_BMCRM00143
crossref_primary_10_3389_fmed_2023_1283454
crossref_primary_10_3390_pathogens12070901
Cites_doi 10.1007/s00705-015-2363-9
10.1371/journal.pone.0122975
10.1038/mt.2011.164
10.1155/2012/829584
10.1016/j.cmi.2016.04.007
10.1128/JVI.01839-13
10.1371/journal.ppat.1003818
10.1006/viro.2002.1545
10.1111/j.1469-0691.2011.03690.x
10.1093/jmicro/dfr084
10.1128/JCM.02002-09
10.1128/JVI.76.10.4679-4687.2002
10.1006/bbrc.1997.7765
10.3402/jev.v5.29497
10.1128/CMR.14.1.98-113.2001
10.1371/journal.ppat.1003018
10.1371/journal.ppat.1004424
10.3402/jev.v3.26913
10.1083/jcb.201211138
10.1016/j.mib.2016.05.004
10.1016/j.virusres.2016.03.003
10.1002/jmv.20426
10.1002/jmv.20756
10.1016/j.jim.2015.12.011
10.1039/C5OB01451D
10.1016/j.healun.2013.12.007
10.1007/s00018-011-0689-3
10.1038/nature12029
10.1007/s13311-016-0450-6
10.1128/JVI.01101-07
10.1007/s11262-016-1292-3
10.1128/JVI.02804-15
10.1016/S1386-6532(01)00157-3
10.1002/rmv.668
10.1016/j.chest.2017.06.026
10.1086/315440
10.1007/s10096-012-1744-1
10.1097/01.aids.0000174456.08992.2b
10.1016/j.cell.2013.10.034
10.1128/JCM.43.9.4807-4810.2005
10.1038/nrm.2017.125
10.1016/j.virol.2009.08.036
10.1093/infdis/jit423
ContentType Journal Article
Copyright COPYRIGHT 2018 BioMed Central Ltd.
Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2018
Copyright_xml – notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2018
DBID AAYXX
CITATION
NPM
ISR
3V.
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOA
DOI 10.1186/s12985-018-1055-y
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
AGRICOLA
PubMed
Publicly Available Content Database



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1743-422X
EndPage 145
ExternalDocumentID oai_doaj_org_article_132199c033074aba94015cefbcbcb338
PMC6149034
A557714352
30236130
10_1186_s12985_018_1055_y
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GrantInformation_xml – fundername: Istituto di Ricerca Virologica Oretta Bartolomei Corsi
  grantid: 2016
– fundername: ;
  grantid: 2016
GroupedDBID ---
0R~
123
29Q
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAHBH
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
IFM
NPM
PMFND
7U9
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c627t-d13d4dcd8a227777bc7e50722d7bfc1c871e4383d79e1207f508496acfe226683
IEDL.DBID M48
ISSN 1743-422X
IngestDate Wed Aug 27 01:24:46 EDT 2025
Thu Aug 21 14:10:34 EDT 2025
Thu Jul 10 19:32:17 EDT 2025
Fri Jul 11 09:52:38 EDT 2025
Fri Jul 25 07:16:23 EDT 2025
Tue Jun 17 21:11:16 EDT 2025
Tue Jun 10 20:18:58 EDT 2025
Fri Jun 27 03:34:26 EDT 2025
Wed Feb 19 02:41:37 EST 2025
Tue Jul 01 01:44:44 EDT 2025
Thu Apr 24 22:57:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords DNA viral load
Exosomes
Torquetenovirus
Viral persistence
Anelloviruses
HIV, transplant recipients
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c627t-d13d4dcd8a227777bc7e50722d7bfc1c871e4383d79e1207f508496acfe226683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-3374-7621
OpenAccessLink https://www.proquest.com/docview/2122941056?pq-origsite=%requestingapplication%
PMID 30236130
PQID 2122941056
PQPubID 55248
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_132199c033074aba94015cefbcbcb338
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6149034
proquest_miscellaneous_2176397803
proquest_miscellaneous_2111152815
proquest_journals_2122941056
gale_infotracmisc_A557714352
gale_infotracacademiconefile_A557714352
gale_incontextgauss_ISR_A557714352
pubmed_primary_30236130
crossref_citationtrail_10_1186_s12985_018_1055_y
crossref_primary_10_1186_s12985_018_1055_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-09-20
PublicationDateYYYYMMDD 2018-09-20
PublicationDate_xml – month: 09
  year: 2018
  text: 2018-09-20
  day: 20
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Virology journal
PublicationTitleAlternate Virol J
PublicationYear 2018
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References M Touinssi (1055_CR14) 2001; 21
B György (1055_CR23) 2011; 68
MR Anderson (1055_CR28) 2016; 13
M Desai (1055_CR7) 2005; 77
N Altan-Bonnet (1055_CR27) 2016; 32
T Nishizawa (1055_CR1) 1997; 241
J Lötvall (1055_CR32) 2014; 3
H Zheng (1055_CR43) 2007; 81
F Maggi (1055_CR3) 2010; 20
RE Crossland (1055_CR30) 2016; 429
X Yin (1055_CR41) 2016; 90
L Mao (1055_CR39) 2016; 52
I De Vlaminck (1055_CR22) 2013; 155
H Kubo (1055_CR24) 2018; 153
J Rocchi (1055_CR44) 2009; 394
SK Li (1055_CR16) 2012; 18
L Li (1055_CR20) 2013; 87
X Osteikoetxea (1055_CR36) 2015; 13
M Nakakoshi (1055_CR33) 2011; 60
M Takahashi (1055_CR40) 2010; 48
F Royo (1055_CR31) 2016; 5
A Riva (1055_CR34) 1974; 19
Z Feng (1055_CR38) 2013; 496
G Raposo (1055_CR25) 2013; 200
M García-Álvarez (1055_CR17) 2013; 32
EO Freed (1055_CR45) 2002; 76
JK Christensen (1055_CR11) 2000; 181
TN Bukong (1055_CR37) 2014; 10
K Thom (1055_CR15) 2007; 79
RP Kincaid (1055_CR6) 2013; 9
A Sagir (1055_CR18) 2005; 19
T Vignolini (1055_CR29) 2016; 217
RP Kincaid (1055_CR5) 2012; 8
S Spandole (1055_CR9) 2015; 160
M Fogli (1055_CR19) 2012; 2012
M Bendinelli (1055_CR2) 2001; 14
K Béland (1055_CR10) 2014; 209
G Van Niel (1055_CR26) 2018; 19
I Görzer (1055_CR12) 2014; 33
X Zhuang (1055_CR42) 2011; 19
H Okamoto (1055_CR4) 2009; 331
D Focosi (1055_CR21) 2016; 22
F Maggi (1055_CR35) 2005; 43
I Görzer (1055_CR13) 2015; 10
LF Mariscal (1055_CR8) 2002; 301
References_xml – volume: 160
  start-page: 893
  year: 2015
  ident: 1055_CR9
  publication-title: Arch Virol
  doi: 10.1007/s00705-015-2363-9
– volume: 10
  start-page: e0122975
  year: 2015
  ident: 1055_CR13
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0122975
– volume: 19
  start-page: 1769
  year: 2011
  ident: 1055_CR42
  publication-title: Mol Ther
  doi: 10.1038/mt.2011.164
– volume: 2012
  start-page: 829584
  year: 2012
  ident: 1055_CR19
  publication-title: Clin Dev Immunol
  doi: 10.1155/2012/829584
– volume: 22
  start-page: 589
  year: 2016
  ident: 1055_CR21
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2016.04.007
– volume: 87
  start-page: 10912
  year: 2013
  ident: 1055_CR20
  publication-title: J Virol
  doi: 10.1128/JVI.01839-13
– volume: 9
  start-page: e1003818
  year: 2013
  ident: 1055_CR6
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003818
– volume: 301
  start-page: 121
  year: 2002
  ident: 1055_CR8
  publication-title: Virology
  doi: 10.1006/viro.2002.1545
– volume: 18
  start-page: 1126
  year: 2012
  ident: 1055_CR16
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2011.03690.x
– volume: 331
  start-page: 1
  year: 2009
  ident: 1055_CR4
  publication-title: Curr Top Microbiol Immunol
– volume: 60
  start-page: 401
  year: 2011
  ident: 1055_CR33
  publication-title: J Electron Microsc
  doi: 10.1093/jmicro/dfr084
– volume: 48
  start-page: 1112
  year: 2010
  ident: 1055_CR40
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02002-09
– volume: 76
  start-page: 4679
  year: 2002
  ident: 1055_CR45
  publication-title: J Virol
  doi: 10.1128/JVI.76.10.4679-4687.2002
– volume: 241
  start-page: 92
  year: 1997
  ident: 1055_CR1
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1997.7765
– volume: 5
  start-page: 294
  year: 2016
  ident: 1055_CR31
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v5.29497
– volume: 14
  start-page: 98
  year: 2001
  ident: 1055_CR2
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.14.1.98-113.2001
– volume: 8
  start-page: e1003018
  year: 2012
  ident: 1055_CR5
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003018
– volume: 10
  start-page: e1004424
  year: 2014
  ident: 1055_CR37
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004424
– volume: 3
  year: 2014
  ident: 1055_CR32
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v3.26913
– volume: 200
  start-page: 373
  year: 2013
  ident: 1055_CR25
  publication-title: J Cell Biol Genet
  doi: 10.1083/jcb.201211138
– volume: 32
  start-page: 77
  year: 2016
  ident: 1055_CR27
  publication-title: Curr Opin Microbiol
  doi: 10.1016/j.mib.2016.05.004
– volume: 217
  start-page: 18
  year: 2016
  ident: 1055_CR29
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2016.03.003
– volume: 77
  start-page: 136
  year: 2005
  ident: 1055_CR7
  publication-title: J Med Virol
  doi: 10.1002/jmv.20426
– volume: 79
  start-page: 1
  year: 2007
  ident: 1055_CR15
  publication-title: J Med Virol
  doi: 10.1002/jmv.20756
– volume: 429
  start-page: 39
  year: 2016
  ident: 1055_CR30
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2015.12.011
– volume: 13
  start-page: 9775
  year: 2015
  ident: 1055_CR36
  publication-title: Org Biomol Chem
  doi: 10.1039/C5OB01451D
– volume: 33
  start-page: 320
  year: 2014
  ident: 1055_CR12
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2013.12.007
– volume: 68
  start-page: 2667
  year: 2011
  ident: 1055_CR23
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-011-0689-3
– volume: 19
  start-page: 105
  year: 1974
  ident: 1055_CR34
  publication-title: J Microsc (Paris)
– volume: 496
  start-page: 367
  year: 2013
  ident: 1055_CR38
  publication-title: Nature
  doi: 10.1038/nature12029
– volume: 13
  start-page: 535
  year: 2016
  ident: 1055_CR28
  publication-title: Neurotherapeutics
  doi: 10.1007/s13311-016-0450-6
– volume: 81
  start-page: 11917
  year: 2007
  ident: 1055_CR43
  publication-title: J Virol
  doi: 10.1128/JVI.01101-07
– volume: 52
  start-page: 189
  year: 2016
  ident: 1055_CR39
  publication-title: Virus Genes
  doi: 10.1007/s11262-016-1292-3
– volume: 90
  start-page: 4232
  year: 2016
  ident: 1055_CR41
  publication-title: J Virol
  doi: 10.1128/JVI.02804-15
– volume: 21
  start-page: 135
  year: 2001
  ident: 1055_CR14
  publication-title: J Clin Virol
  doi: 10.1016/S1386-6532(01)00157-3
– volume: 20
  start-page: 392
  year: 2010
  ident: 1055_CR3
  publication-title: Rev Med Virol
  doi: 10.1002/rmv.668
– volume: 153
  start-page: 210
  year: 2018
  ident: 1055_CR24
  publication-title: Chest
  doi: 10.1016/j.chest.2017.06.026
– volume: 181
  start-page: 1796
  year: 2000
  ident: 1055_CR11
  publication-title: J Infect Dis
  doi: 10.1086/315440
– volume: 32
  start-page: 289
  year: 2013
  ident: 1055_CR17
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-012-1744-1
– volume: 19
  start-page: 1091
  year: 2005
  ident: 1055_CR18
  publication-title: AIDS
  doi: 10.1097/01.aids.0000174456.08992.2b
– volume: 155
  start-page: 1178
  year: 2013
  ident: 1055_CR22
  publication-title: Cell
  doi: 10.1016/j.cell.2013.10.034
– volume: 43
  start-page: 4807
  year: 2005
  ident: 1055_CR35
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.9.4807-4810.2005
– volume: 19
  start-page: 213
  year: 2018
  ident: 1055_CR26
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2017.125
– volume: 394
  start-page: 235
  year: 2009
  ident: 1055_CR44
  publication-title: Virology
  doi: 10.1016/j.virol.2009.08.036
– volume: 209
  start-page: 247
  year: 2014
  ident: 1055_CR10
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jit423
SSID ssj0032679
Score 2.3198574
Snippet Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and successful...
Background Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and...
BACKGROUND: Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a fine and...
Abstract Background Torquetenovirus (TTV) belongs to Anelloviridae family, infects nearly all people indefinitely without causing overt disease establishing a...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 145
SubjectTerms Anelloviridae
Anelloviruses
Annexin II
CD63 antigen
CD81 antigen
Centrifugation
Deoxyribonuclease
deoxyribonucleases
Detergents
DNA
DNA viral load
Electron microscopy
Exosomes
freeze-thaw cycles
Freezing
Genetic aspects
hepatitis C
HIV
HIV infections
HIV, transplant recipients
Human immunodeficiency virus
kidney transplant
Kidney transplantation
Nanoparticles
Patients
Physiological aspects
polymerase chain reaction
Quantitation
Thawing
Torquetenovirus
vertebrate viruses
Vesicles
Viral genetics
viral load
Viral persistence
Viremia
Western blotting
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9UwFA4yUHwRnb-qU6IIglDWpkmTPE5xTGE-6AYDH0KapNsF146be8fuf79z0t7LLcJ8sX1rTkt7zknOd8jpdwj5IJ0NpS94rrSwOQdglOsAviyZq3jjW1YnntnjH_XRKf9-Js62Wn1hTdhADzwobh-ypVJrV0DeLbltrIaEQLjQNg5OyK9w9YWYt06mhjUYMInU4x5mqer9CFFNYZEaUpkKka8mUSiR9f-9JG_FpGm95FYAOnxMHo3IkR4Mb_yE3AvdLrk_9JJc7ZIHx-Mu-VPy-6Sfw7MBDffXs_kyUh8WqeKqo7OOhps-9pchUvAcrAP19DrEVBxH3WzuUjuv7hwlU_8-egX4-tLSaJFHOD4jp4dfT74c5WMThdyBmhe5LyvPvfPKMibhaJwMgAEZ87JpXekgYQpIV-qlDiUrZAuIjevaujYAMqtV9ZzsdH0XXhLKZduESnik9OMFD03d-kZ55kqtYCa3GSnWSjVuZBjHRhd_TMo0VG0GOxiwg0E7mFVGPm1uuRroNe4S_oyW2ggiM3a6AP5iRn8x__KXjLxHOxvkvuiwuObcLmM03379NAdCSGwHL1hGPo5CbQ9f4Oz4rwLoAemyJpJ7E0mYnG46vHYnMy4O0QBaYBrLa-uMvNsM451Y8NaFfokycAimSnGXjMRtWVVUGXkxeOhGN9gLClPDjMiJ706UNx3pZheJXhwAmy4q_up_aPs1echw1uE2XrFHdhbzZXgDKG7RvE0T9haUKEOW
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgCLQXBOMrMFBASEhI0RLHjpMnNBDTQBoPsEmVeLAc2ymVWNLF7UT_e-4cNyxCavpWX6r2vvy7-Po7Qt4KrWxmUpaUFVcJA2CUVBZ8WVCds9o0tPA8s2ffitML9nXGZ-GBmwttlduc6BO16TQ-Iz-CFEsr7EksPiyvEpwahaerYYTGbXIHqcuwpUvMxoILkInn2kPQnTBKZ-FUMyuLIwf7XIlta0huynmymexLnr7__yR9Y5eadlDe2JJOHpD7AUvGx4PxH5Jbtj0gd4fpkpsDcu8snJs_Ij_Pux4-G_Bxd73o1y42duV7sNp40cb2T-e6S-ti8CXsDDXxtXW-XS7Wi177AV_tHCX9RL94CYj7UsVOIbOwe0wuTj6ffzpNwliFRIPiV4nJcsOMNqWiVMBVa2EBFVJqRN3oTEMJZZHA1IjKZjQVDWA4VhVKNxawWlHmT8he27X2GYmZaGqbc4Mkfyxlti4aU5eG6qwqIbabiKRbpUodOMdx9MVv6WuPspCDHSTYQaId5CYi78dblgPhxi7hj2ipURC5sv0bXT-XIfQk1NtZVek0h3TGVK0qKCm5tk2t4QUVekTeoJ0lsmG02G4zV2vn5Jcf3-Ux5wIHxHMakXdBqOngF2gV_r0AekACrYnk4UQSwlVPl7fuJEO6cPKfc0fk9biMd2ILXGu7NcrAxWmZ8V0yAg9qyzSPyNPBQ0fd4HQoLBYjIia-O1HedKVd_PKE4wDhqjRnz3d_9Rdkn2I84ZFdekj2Vv3avgTEtqpf-bD8C96zPRQ
  priority: 102
  providerName: ProQuest
Title Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples
URI https://www.ncbi.nlm.nih.gov/pubmed/30236130
https://www.proquest.com/docview/2122941056
https://www.proquest.com/docview/2111152815
https://www.proquest.com/docview/2176397803
https://pubmed.ncbi.nlm.nih.gov/PMC6149034
https://doaj.org/article/132199c033074aba94015cefbcbcb338
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9tAEB7yoKWX0qYvtalRS6FQUCutVlrpUIpTElKDQ0liMPSwSLsr15BIqWSH-N93ZiWbiIZQ-WDwjoQ9D8032vE3AB-Eykygfe4laZR5HIGRlxr0ZcFUyHNdsNjyzI5P4uMJH02j6Rasx1t1CmzuLO1ontSkvvh882f1DQP-qw34JP7SYM5KqAWNiEqjyFttwy4mJkFxOuabTQUEKpZ6jzC4xxmbdpucd16il6Ysm_-_9-xbSavfUHkrQx09gccdtHSHrS88hS1T7sGDdtjkag8ejrtt9Gfw67yq8doIl6vreb1sXG0WtiWrdOela26qpro0jYuuRY2i2r02je2ec9W8VnbeVzkjSTvgz71CAH6ZuU1GRMPNc5gcHZ5_P_a6KQueQjssPB2Emmulk4wxgUeuhEGQyJgWeaEChRWVIT5TLVITMF8UCOl4GmeqMAjd4iR8ATtlVZpX4HJR5CaMNHH-cZ-bPC50nmimgjTBUC8c8NdKlaqjIKdJGBfSliJJLFs7SLSDJDvIlQOfNqdctfwb9wkfkKU2gkSdbT-o6pnsIlFi-R2kqfJDvLvxLM9SrDAjZYpc4QsLdgfek50lkWOU1H0zy5ZNI3-cncphFAmaFx8xBz52QkWFv0Bl3Z8ZUA_Ep9WT3O9JYvSq_vLaneTa-SXCCZZS_23swLvNMp1JHXGlqZYkg0fEkiC6T0bQvm3ihw68bD10oxsaFkW1owOi57s95fVXyvlvyz-OiC71Q_76P77bG3jEKKhoG8_fh51FvTRvEcUt8gFsi6kYwO5wODob4fvB4cnP04F9JjKwcfsXW2dHZQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVDwuCMrLUMAgEBKSVXu9fh0QaqFVQpsIlVSKxGGxd9chErWDnRTyp_iNzPgRaiHlVvvmHTvJzuzMN9nxNwCvAhlrR9ncCiMvtjgCIyvSaMsBky5PVMr8imd2OPL7Z_zTxJtswZ_2XRgqq2x9YuWoVS7pP_I9dLEsoppE__38p0Vdo2h3tW2hUZvFsV79wpStfDf4iPp9zdjR4fhD32q6ClgSP3dhKcdVXEkVxowFeCQy0AiKGFNBkkpHYgahib9TBZF2mB2kCGF45Mcy1QhV_NDF516Dbe5iKtOD7YPD0efT1vcjFqrY_QjmW5yxSbOP6oT-XomRNaRCOaJT9Txr1YmEVcOA_8PCpbjYrdm8FASP7sDtBr2a-7W53YUtne3A9bqf5WoHbgybnfp78HWcF_hsROT5xaxYlqbSi6rqKzNnmal_52V-rksTrZdqUZV5ocuqQM-Us0JWLcWyKUlWPQTNOWL889gsY-IyLu_D2ZVM-QPoZXmmH4HJgzTRrqeIVpDbXCd-qpJQMelEIXqT1AC7nVQhG5ZzarbxQ1TZTuiLWg8C9SBID2JlwNv1LfOa4mOT8AFpai1I7NzVhbyYimaxC8zwnSiStosOlMdJHGES60mdJhJP1w0NeEl6FsS_kVGBzzRelqUYfDkV-54XUEt6jxnwphFKc_wFMm7el8B5IMqujuRuRxIdhOwOt-YkGgdVin_LyYAX62G6k4ruMp0vSQYPj4WOt0kmoK3h0HYNeFhb6HpuqB8VpacGBB3b7UxedySbfa8ozhE0RrbLH2_-6s_hZn88PBEng9HxE7jFaG3RhqG9C71FsdRPES8ukmfNIjXh21X7hb-r13qB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Torquetenovirus+detection+in+exosomes+enriched+vesicles+circulating+in+human+plasma+samples&rft.jtitle=Virology+journal&rft.au=Martelli%2C+Francesco&rft.au=Macera%2C+Lisa&rft.au=Spezia%2C+Pietro+Giorgio&rft.au=Medici%2C+Chiara&rft.date=2018-09-20&rft.issn=1743-422X&rft.eissn=1743-422X&rft.volume=15&rft.issue=1&rft.spage=145&rft_id=info:doi/10.1186%2Fs12985-018-1055-y&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon